Medacta Group SA (MOVE.SW)
- Previous Close
108.40 - Open
111.00 - Bid --
- Ask --
- Day's Range
109.60 - 111.00 - 52 Week Range
98.10 - 135.00 - Volume
8,319 - Avg. Volume
9,566 - Market Cap (intraday)
2.204B - Beta (5Y Monthly) 1.15
- PE Ratio (TTM)
47.67 - EPS (TTM)
2.32 - Earnings Date Mar 13, 2024
- Forward Dividend & Yield 0.55 (0.50%)
- Ex-Dividend Date May 10, 2024
- 1y Target Est
143.61
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
www.medacta.comRecent News: MOVE.SW
Performance Overview: MOVE.SW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MOVE.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MOVE.SW
Valuation Measures
Market Cap
2.20B
Enterprise Value
2.38B
Trailing P/E
47.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.42
Price/Book (mrq)
6.82
Enterprise Value/Revenue
4.66
Enterprise Value/EBITDA
19.33
Financial Highlights
Profitability and Income Statement
Profit Margin
9.27%
Return on Assets (ttm)
7.47%
Return on Equity (ttm)
15.67%
Revenue (ttm)
510.78M
Net Income Avi to Common (ttm)
47.36M
Diluted EPS (ttm)
2.32
Balance Sheet and Cash Flow
Total Cash (mrq)
20.79M
Total Debt/Equity (mrq)
61.74%
Levered Free Cash Flow (ttm)
-35.12M
Research Analysis: MOVE.SW
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: MOVE.SW
MOVE.SW does not have Company Insights